Nitzan Rosenfeld, Ph.D. - Publications

Affiliations: 
2005 Weizmann Institute of Science, Rehovot, Israel 
Area:
Bioinformatics Biology, General Biophysics

32/88 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, ... ... Rosenfeld N, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nature Communications. 7: 11479. PMID 27161491 DOI: 10.1038/ncomms11479  0.64
2016 Swanton C, Soria JC, Bardelli A, Biankin A, Caldas C, Chandarlapaty S, de Koning L, Dive C, Feunteun J, Leung SY, Marais R, Mardis ER, McGranahan N, Middleton G, Quezada SA, ... ... Rosenfeld N, et al. Consensus on precision medicine for metastatic cancers: A report from the MAP conference. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 27143638 DOI: 10.1093/annonc/mdw192  0.64
2015 Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin SF, Tsui DW, Marass F, Gale D, Ali HR, Shah P, Contente-Cuomo T, Farahani H, Shumansky K, ... ... Rosenfeld N, et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nature Communications. 6: 8760. PMID 26530965 DOI: 10.1038/ncomms9760  0.64
2015 Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, ... ... Rosenfeld N, et al. Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nature Communications. 6: 6605. PMID 25827447 DOI: 10.1038/ncomms7605  0.64
2015 Mouliere F, Rosenfeld N. Circulating tumor-derived DNA is shorter than somatic DNA in plasma. Proceedings of the National Academy of Sciences of the United States of America. 112: 3178-9. PMID 25733911 DOI: 10.1073/pnas.1501321112  0.64
2015 Schwarz RF, Ng CK, Cooke SL, Newman S, Temple J, Piskorz AM, Gale D, Sayal K, Murtaza M, Baldwin PJ, Rosenfeld N, Earl HM, Sala E, Jimenez-Linan M, Parkinson CA, et al. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. Plos Medicine. 12: e1001789. PMID 25710373 DOI: 10.1371/Journal.Pmed.1001789  0.64
2014 Weaver JM, Ross-Innes CS, Shannon N, Lynch AG, Forshew T, Barbera M, Murtaza M, Ong CA, Lao-Sirieix P, Dunning MJ, Smith L, Smith ML, Anderson CL, Carvalho B, O'Donovan M, ... ... Rosenfeld N, et al. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nature Genetics. 46: 837-43. PMID 24952744 DOI: 10.1038/Ng.3013  0.64
2014 Gossage L, Murtaza M, Slatter AF, Lichtenstein CP, Warren A, Haynes B, Marass F, Roberts I, Shanahan SJ, Claas A, Dunham A, May AP, Rosenfeld N, Forshew T, Eisen T. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma. Genes, Chromosomes & Cancer. 53: 38-51. PMID 24166983 DOI: 10.1002/gcc.22116  0.64
2013 Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A, Maniero C, Garg S, Bochukova EG, Zhao W, Shaikh LH, Brighton CA, Teo AE, Davenport AP, Dekkers T, ... ... Rosenfeld N, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nature Genetics. 45: 1055-60. PMID 23913004 DOI: 10.1038/Ng.2716  0.64
2013 Dawson SJ, Rosenfeld N, Caldas C. Circulating tumor DNA to monitor metastatic breast cancer. The New England Journal of Medicine. 369: 93-4. PMID 23822788 DOI: 10.1056/NEJMc1306040  0.64
2013 Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, Parkinson C, Chin SF, Kingsbury Z, Wong AS, Marass F, Humphray S, Hadfield J, Bentley D, Chin TM, ... ... Rosenfeld N, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 497: 108-12. PMID 23563269 DOI: 10.1038/nature12065  0.64
2013 Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, Halsall D, Wallis M, ... ... Rosenfeld N, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. The New England Journal of Medicine. 368: 1199-209. PMID 23484797 DOI: 10.1056/NEJMoa1213261  0.64
2012 Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, Dawson SJ, Piskorz AM, Jimenez-Linan M, Bentley D, Hadfield J, May AP, Caldas C, Brenton JD, Rosenfeld N. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Science Translational Medicine. 4: 136ra68. PMID 22649089 DOI: 10.1126/scitranslmed.3003726  0.64
2012 Young JW, Locke JC, Altinok A, Rosenfeld N, Bacarian T, Swain PS, Mjolsness E, Elowitz MB. Measuring single-cell gene expression dynamics in bacteria using fluorescence time-lapse microscopy. Nature Protocols. 7: 80-8. PMID 22179594 DOI: 10.1038/Nprot.2011.432  0.64
2011 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World Journal of Gastroenterology : Wjg. 17: 3976-85. PMID 22046085 DOI: 10.3748/wjg.v17.i35.3976  0.64
2010 Benjamin H, Lebanony D, Rosenwald S, Cohen L, Gibori H, Barabash N, Ashkenazi K, Goren E, Meiri E, Morgenstern S, Perelman M, Barshack I, Goren Y, Edmonston TB, Chajut A, ... ... Rosenfeld N, et al. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. The Journal of Molecular Diagnostics : Jmd. 12: 771-9. PMID 20864637 DOI: 10.2353/jmoldx.2010.090169  0.64
2010 Barshack I, Meiri E, Rosenwald S, Lebanony D, Bronfeld M, Aviel-Ronen S, Rosenblatt K, Polak-Charcon S, Leizerman I, Ezagouri M, Zepeniuk M, Shabes N, Cohen L, Tabak S, Cohen D, ... ... Rosenfeld N, et al. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression. The International Journal of Biochemistry & Cell Biology. 42: 1355-62. PMID 20619223 DOI: 10.1016/j.biocel.2009.02.021  0.64
2010 Fridman E, Dotan Z, Barshack I, David MB, Dov A, Tabak S, Zion O, Benjamin S, Benjamin H, Kuker H, Avivi C, Rosenblatt K, Polak-Charcon S, Ramon J, Rosenfeld N, et al. Accurate molecular classification of renal tumors using microRNA expression. The Journal of Molecular Diagnostics : Jmd. 12: 687-96. PMID 20595629 DOI: 10.2353/jmoldx.2010.090187  0.64
2010 Rosenwald S, Gilad S, Benjamin S, Lebanony D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E, Barshack I, Nass D, Tobar A, Feinmesser M, Rosenfeld N, et al. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 23: 814-23. PMID 20348879 DOI: 10.1038/modpathol.2010.57  0.64
2009 Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2030-7. PMID 19273703 DOI: 10.1200/JCO.2008.19.4134  0.64
2009 Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O, Sitbon E, Lithwick Yanai G, Elyakim E, Cholakh H, Gibori H, ... ... Rosenfeld N, et al. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathology (Zurich, Switzerland). 19: 375-83. PMID 18624795 DOI: 10.1111/j.1750-3639.2008.00184.x  0.64
2009 Mansukhani MM, Rosenfeld N. Reply to G. Rossi et al Journal of Clinical Oncology. 27. DOI: 10.1200/JCO.2009.24.0903  0.64
2008 Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, et al. MicroRNAs accurately identify cancer tissue origin. Nature Biotechnology. 26: 462-9. PMID 18362881 DOI: 10.1038/nbt1392  0.64
2007 Rosenfeld N, Young JW, Alon U, Swain PS, Elowitz MB. Accurate prediction of gene feedback circuit behavior from component properties. Molecular Systems Biology. 3: 143. PMID 18004276 DOI: 10.1038/Msb4100185  0.64
2007 Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Molecular Cell. 26: 731-43. PMID 17540598 DOI: 10.1016/J.Molcel.2007.05.017  0.64
2006 Sigal A, Milo R, Cohen A, Geva-Zatorsky N, Klein Y, Liron Y, Rosenfeld N, Danon T, Perzov N, Alon U. Variability and memory of protein levels in human cells. Nature. 444: 643-6. PMID 17122776 DOI: 10.1038/nature05316  0.64
2006 Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, Dekel E, Yarnitzky T, Liron Y, Polak P, Lahav G, Alon U. Oscillations and variability in the p53 system. Molecular Systems Biology. 2: 2006.0033. PMID 16773083 DOI: 10.1038/msb4100068  0.64
2006 Rosenfeld N, Perkins TJ, Alon U, Elowitz MB, Swain PS. A fluctuation method to quantify in vivo fluorescence data. Biophysical Journal. 91: 759-66. PMID 16648159 DOI: 10.1529/Biophysj.105.073098  0.64
2005 Rosenfeld N, Young JW, Alon U, Swain PS, Elowitz MB. Gene regulation at the single-cell level. Science (New York, N.Y.). 307: 1962-5. PMID 15790856 DOI: 10.1126/Science.1106914  0.64
2004 Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB, Alon U. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nature Genetics. 36: 147-50. PMID 14730303 DOI: 10.1038/Ng1293  0.64
2003 Rosenfeld N, Alon U. Response delays and the structure of transcription networks. Journal of Molecular Biology. 329: 645-54. PMID 12787666 DOI: 10.1016/S0022-2836(03)00506-0  0.64
2002 Rosenfeld N, Elowitz MB, Alon U. Negative autoregulation speeds the response times of transcription networks. Journal of Molecular Biology. 323: 785-93. PMID 12417193 DOI: 10.1016/S0022-2836(02)00994-4  0.64
Low-probability matches
2020 Gill AB, Rundo L, Wan JCM, Lau D, Zawaideh JP, Woitek R, Zaccagna F, Beer L, Gale D, Sala E, Couturier DL, Corrie PG, Rosenfeld N, Gallagher FA. Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma. Cancers. 12. PMID 33255267 DOI: 10.3390/cancers12123493  0.01
2020 Biasci D, Smoragiewicz M, Connell CM, Wang Z, Gao Y, Thaventhiran JED, Basu B, Magiera L, Johnson TI, Bax L, Gopinathan A, Isherwood C, Gallagher FA, Pawula M, Hudecova I, ... ... Rosenfeld N, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proceedings of the National Academy of Sciences of the United States of America. PMID 33127761 DOI: 10.1073/pnas.2013644117  0.01
2020 Mittempergher L, Piskorz AM, Bosma AJ, Michaut M, Wisman GBA, Kluin RJC, Nieuwland M, Brugman W, van der Ven KJW, Marass F, Morris J, Rosenfeld N, Jimenez-Linan M, de Jong S, van der Zee AGJ, et al. Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene. Plos One. 15: e0235766. PMID 32639993 DOI: 10.1371/journal.pone.0235766  0.01
2020 Wan JCM, Heider K, Gale D, Murphy S, Fisher E, Mouliere F, Ruiz-Valdepenas A, Santonja A, Morris J, Chandrananda D, Marshall A, Gill AB, Chan PY, Barker E, Young G, ... ... Rosenfeld N, et al. ctDNA monitoring using patient-specific sequencing and integration of variant reads. Science Translational Medicine. 12. PMID 32554709 DOI: 10.1126/scitranslmed.aaz8084  0.01
2020 Nygård L, Ahlborn LB, Persson GF, Chandrananda D, Langer JW, Fischer BM, Langer SW, Gabrielaite M, Kjær A, Rosenfeld N, Mouliere F, Østrup O, Vogelius IR, Bentzen SM. Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations. Plos One. 15: e0231884. PMID 32343749 DOI: 10.1371/journal.pone.0231884  0.01
2020 Heider K, Wan JCM, Hall J, Belic J, Boyle S, Hudecova I, Gale D, Cooper WN, Corrie PG, Brenton JD, Smith CG, Rosenfeld N. Detection of ctDNA from Dried Blood Spots after DNA Size Selection. Clinical Chemistry. PMID 32268361 DOI: 10.1093/clinchem/hvaa050  0.01
2020 Smith CG, Moser T, Mouliere F, Field-Rayner J, Eldridge M, Riediger AL, Chandrananda D, Heider K, Wan JCM, Warren AY, Morris J, Hudecova I, Cooper WN, Mitchell TJ, Gale D, ... ... Rosenfeld N, et al. Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors. Genome Medicine. 12: 23. PMID 32111235 DOI: 10.1186/s13073-020-00723-8  0.01
2020 Heider K, Gale DG, Marsico G, Ruiz-Valdepeñas A, Sharma G, Perry M, Osborne R, Howarth K, Rundell V, Belic J, Wulff J, Harden S, Rassl DM, Rintoul R, Rosenfeld N. Detection of residual disease and recurrence in early-stage non-small cell lung cancer (NSCLC) patients using sensitive personalized ctDNA sequencing assays. Journal of Clinical Oncology. 38: e15560-e15560. DOI: 10.1200/jco.2020.38.15_suppl.e15560  0.01
2019 Pritchett MA, Camidge DR, Patel M, Khatri J, Boniol S, Friedman EK, Khomani A, Dalia S, Baker-Neblett K, Plagnol V, Howarth KD, Jones GR, Rosenfeld N, Morris CD, Govindan R. Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer. Jco Precision Oncology. 3. PMID 32914040 DOI: 10.1200/PO.18.00299  0.01
2019 Remon J, Lacroix L, Jovelet C, Caramella C, Howarth K, Plagnol V, Rosenfeld N, Morris C, Mezquita L, Pannet C, Ngocamus M, Le Pechoux C, Adam J, Grecea AM, Planchard D, et al. Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non-Small-Cell Lung Cancer. Jco Precision Oncology. 3. PMID 32914037 DOI: 10.1200/PO.18.00211  0.01
2019 Smith C, Heitzer E, Moser T, Mouliere F, Chandrananda D, Mitchell T, Warren A, Burge J, Armitage J, Riddick T, Aho T, Eldridge M, Massie C, Rosenfeld N, Stewart G. LBA-14 COMPREHENSIVE CHARACTERISATION OF CIRCULATING TUMOUR DNA IN PLASMA AND URINE OF PATIENTS WITH RENAL TUMOURS: RESULTS OF THE DIAMOND AND MONREC STUDIES Journal of Urology. 201. DOI: 10.1097/01.JU.0000557506.46205.f9  0.01
2019 Nygaard L, Ahlborn L, Persson G, Chandrananda D, Langer J, Fischer B, Aznar M, Langer S, Gabrielaite M, Kjær A, Rosenfeld N, Mouliere F, Østrup O, Vogelius I, Bentzen S. EP-1368 Circulating cell free DNA during chemoradiotherapy in non-small cell lung cancer patients Radiotherapy and Oncology. 133: S747-S748. DOI: 10.1016/S0167-8140(19)31788-8  0.01
2018 Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, Mair R, Goranova T, Marass F, Heider K, Wan JCM, Supernat A, Hudecova I, Gounaris I, Ros S, ... ... Rosenfeld N, et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Science Translational Medicine. 10. PMID 30404863 DOI: 10.1126/Scitranslmed.Aat4921  0.01
2018 Mouliere F, Mair R, Chandrananda D, Marass F, Smith CG, Su J, Morris J, Watts C, Brindle KM, Rosenfeld N. Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients. Embo Molecular Medicine. PMID 30401727 DOI: 10.15252/Emmm.201809323  0.01
2018 Mair R, Mouliere F, Smith CG, Chandrananda D, Gale D, Marass F, Tsui DWY, Massie CE, Wright AJ, Watts C, Rosenfeld N, Brindle KM. Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models. Cancer Research. PMID 30389699 DOI: 10.1158/0008-5472.Can-18-0074  0.01
2018 Risberg B, Tsui DW, Biggs H, Ruiz-Valdepenas Martin de Almagro A, Dawson SJ, Hodgkin C, Jones L, Parkinson C, Piskorz A, Marass F, Chandrananda D, Moore E, Morris J, Plagnol V, Rosenfeld N, et al. Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients. The Journal of Molecular Diagnostics : Jmd. PMID 30165204 DOI: 10.1016/J.Jmoldx.2018.07.005  0.01
2018 Tsui DWY, Murtaza M, Wong ASC, Rueda OM, Smith CG, Chandrananda D, Soo RA, Lim HL, Goh BC, Caldas C, Forshew T, Gale D, Liu W, Morris J, Marass F, ... ... Rosenfeld N, et al. Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer. Embo Molecular Medicine. PMID 29848757 DOI: 10.15252/emmm.201707945  0.01
2018 Gale D, Lawson ARJ, Howarth K, Madi M, Durham B, Smalley S, Calaway J, Blais S, Jones G, Clark J, Dimitrov P, Pugh M, Woodhouse S, Epstein M, Fernandez-Gonzalez A, ... ... Rosenfeld N, et al. Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA. Plos One. 13: e0194630. PMID 29547634 DOI: 10.1371/Journal.Pone.0194630  0.01
2018 Plagnol V, Woodhouse S, Howarth K, Lensing S, Smith M, Epstein M, Madi M, Smalley S, Leroy C, Hinton J, de Kievit F, Musgrave-Brown E, Herd C, Baker-Neblett K, Brennan W, ... ... Rosenfeld N, et al. Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling. Plos One. 13: e0193802. PMID 29543828 DOI: 10.1371/Journal.Pone.0193802  0.01
2018 Goldman JW, Noor ZS, Remon J, Besse B, Rosenfeld N. Are liquid biopsies a surrogate for tissue EGFR testing? Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: i38-i46. PMID 29462257 DOI: 10.1093/annonc/mdx706  0.01
2018 Patel K, Massie C, Marass F, Morris J, Lynch A, Mouliere F, Neal D, Gnanapragasam V, Forshew T, Rosenfeld N. PD56-03 DETECTION OF PRIVATE CLONAL MUTATIONS IN LOCALISED PROSTATE CANCER FROM RARE MOLECULES OF CIRCULATING TUMOUR DNA Journal of Urology. 199. DOI: 10.1016/j.juro.2018.02.2635  0.01
2018 Govindan R, Pritchett M, Camidge D, Patel M, Khatri J, Boniol S, Friedman E, Khomani A, Dalia S, Baker-Neblett K, Plagnol V, Howarth K, Rosenfeld N, Morris C. MA16.02 Prospective Clinical Validation of the InVisionFirst™ ctDNA Assay for Molecular Profiling of Patients with Advanced NSCLC Journal of Thoracic Oncology. 13: S411-S412. DOI: 10.1016/J.Jtho.2018.08.449  0.01
2018 Remon J, Jovelet C, Lacroix L, Planchard D, Mezquita L, Howarth K, Green E, Plagnol V, Morris C, Rosenfeld N, Caramella C, Lepéchoux C, Aboubakar Nana F, Botticella A, Adam J, et al. P2.13-24 Prospective Efficacy of Osimertinib in Circulating Tumour DNA (ctDNA) T790M-Mutant NSCLC Patients Journal of Thoracic Oncology. 13: S807-S808. DOI: 10.1016/J.Jtho.2018.08.1419  0.01
2017 Fribbens C, Garcia Murillas I, Beaney M, Hrebien S, O'Leary B, Kilburn L, Howarth K, Epstein M, Green E, Rosenfeld N, Ring A, Johnston S, Turner N. Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29045530 DOI: 10.1093/annonc/mdx483  0.01
2017 Patel KM, van der Vos KE, Smith CG, Mouliere F, Tsui D, Morris J, Chandrananda D, Marass F, van den Broek D, Neal DE, Gnanapragasam VJ, Forshew T, van Rhijn BW, Massie CE, Rosenfeld N, et al. Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer. Scientific Reports. 7: 5554. PMID 28717136 DOI: 10.1038/s41598-017-05623-3  0.01
2017 Mock A, Murphy S, Morris J, Marass F, Rosenfeld N, Massie C. CVE: an R package for interactive variant prioritisation in precision oncology. Bmc Medical Genomics. 10: 37. PMID 28545463 DOI: 10.1186/s12920-017-0261-6  0.01
2017 Wan JC, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nature Reviews. Cancer. PMID 28233803 DOI: 10.1038/nrc.2017.7  0.01
2017 Remon J, Caramella C, Jovelet C, Lacroix L, Lawson A, Smalley S, Howarth K, Gale D, Green E, Plagnol V, Rosenfeld N, Planchard D, Bluthgen MV, Gazzah A, Pannet C, et al. Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28104619 DOI: 10.1093/Annonc/Mdx017  0.01
2017 Wan J, Murphy S, Gale DG, Morris JA, Mouliere F, Gill A, Marass F, Heider K, Parkinson C, Gallagher FA, Durrani AJ, McDermott U, Massie C, Corrie P, Rosenfeld N. A pilot study of individualised monitoring of patients with metastatic melanoma using plasma and urine DNA. Journal of Clinical Oncology. 35: e21032-e21032. DOI: 10.1200/jco.2017.35.15_suppl.e21032  0.01
2017 Fribbens CV, Garcia-Murillas I, Beaney M, Hrebien S, Howarth K, Epstein M, Rosenfeld N, Ring AE, Johnston SRD, Turner NC. Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA (ctDNA) in metastatic breast cancer. Journal of Clinical Oncology. 35: 1015-1015. DOI: 10.1200/JCO.2017.35.15_suppl.1015  0.01
2017 Wan J, Murphy S, Gale D, Morris J, Mouliere FC, Marass F, Heider K, Chandrananda D, Bignell G, Parkinson C, Durrani A, McDermott U, Massie C, Corrie P, Rosenfeld N. Individualised monitoring of patients with metastatic melanoma using plasma DNA The Lancet. 389: S99. DOI: 10.1016/S0140-6736(17)30495-6  0.01
2017 Ruiz-Valdepenas A, Heider K, Doughton G, Qian W, Massie C, Chandrananda D, Smith C, Gale D, Moseley E, Castedo C, Stone A, Thorbinson C, Eisen T, Rassl D, Harden S, ... ... Rosenfeld N, et al. MA 11.02 Circulating Tumor DNA in Early Stage NSCLC: High Sensitivity Analysis in Low Burden Disease. LUCID Study Update Journal of Thoracic Oncology. 12: S1843-S1844. DOI: 10.1016/J.JTHO.2017.09.543  0.01
2017 Remon J, Caramella C, Joelet C, Lacroix L, Lawson A, Smalley S, Howarth K, Gale D, Rosenfeld N, Green E, Plagnol V, Planchard D, Bluthgen M, Gazzah A, Pannet C, et al. P3.02b-102 Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients Journal of Thoracic Oncology. 12: S1254-S1255. DOI: 10.1016/J.Jtho.2016.11.1770  0.01
2017 Forshew T, Lawson A, Smalley S, Plagnol V, Calaway J, Blais S, Howarth K, Jones G, Pugh M, Madi M, Durham B, Musgrave-Brown E, Woodhouse S, Rosenfeld N, Gale D, et al. P2.03b-093 Validation and Performance of a Standardized ctDNA NGS Assay across Two Laboratories Journal of Thoracic Oncology. 12: S992-S993. DOI: 10.1016/J.Jtho.2016.11.1375  0.01
2016 Parkinson CA, Gale D, Piskorz AM, Biggs H, Hodgkin C, Addley H, Freeman S, Moyle P, Sala E, Sayal K, Hosking K, Gounaris I, Jimenez-Linan M, Earl HM, Qian W, ... Rosenfeld N, et al. Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study. Plos Medicine. 13: e1002198. PMID 27997533 DOI: 10.1371/journal.pmed.1002198  0.01
2016 Köbel M, Piskorz AM, Lee S, Lui S, LePage C, Marass F, Rosenfeld N, Mes Masson AM, Brenton JD. Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. The Journal of Pathology. Clinical Research. 2: 247-258. PMID 27840695 DOI: 10.1002/cjp2.53  0.01
2016 Pereira B, Chin SF, Rueda OM, Vollan HM, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, ... ... Rosenfeld N, et al. Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nature Communications. 7: 11908. PMID 27264733 DOI: 10.1038/ncomms11908  0.01
2016 Marass F, Mouliere F, Yuan K, Rosenfeld N, Markowetz F. A phylogenetic latent feature model for clonal deconvolution The Annals of Applied Statistics. 10: 2377-2404. DOI: 10.1214/16-AOAS986  0.01
2016 Parkinson CA, Gale D, Piskorz A, Hodgkin C, Biggs H, Addley H, Moyle P, Freeman S, Sala E, Hosking K, Gounaris I, Jimenez-Linan M, Earl HM, Qian W, Rosenfeld N, et al. Circulating tumour DNA carrying patient-specific mutations in TP53 as an early response biomarker in relapsed high grade serous ovarian cancer. Journal of Clinical Oncology. 34: e23040-e23040. DOI: 10.1200/jco.2016.34.15_suppl.e23040  0.01
2016 Remon J, Soria J, Lacroix L, Howarth K, Lawson A, Smalley S, Gale D, Plagnol V, Green E, Rosenfeld N, Jovelet C, Pannet C, Besse B. Evaluation of liquid biopsies for molecular profiling and monitoring in non-small cell lung cancer (NSCLC) patients. Journal of Clinical Oncology. 34: 11533-11533. DOI: 10.1200/Jco.2016.34.15_Suppl.11533  0.01
2016 Garcia-Corbacho J, Mouliere F, Carr H, Morris JA, Marrass F, Gale DG, Kumar S, Hategan M, Zabrautanu M, Dott W, Harrington EA, Dougherty BA, Barrett JC, Basu B, Brenton JD, ... ... Rosenfeld N, et al. CALIBRATE: Intensive profiling of circulating tumour DNA (ctDNA) from patients participating in experimental therapeutics trials including mutational profiles and copy number changes. Journal of Clinical Oncology. 34: 11530-11530. DOI: 10.1200/jco.2016.34.15_suppl.11530  0.01
2016 Murphy S, Wan J, Gale D, Morris J, Mouliere F, Bignell G, Alifrangis C, Parkinson C, Durrani A, McDermott U, Massie C, Corrie P, Rosenfeld N. Monitoring metastatic melanoma treatment resistance using circulating tumour DNA European Journal of Cancer. 61: S196. DOI: 10.1016/S0959-8049(16)61694-5  0.01
2016 Massie C, Rosenfeld N. Proffered Paper: Enhancing sensitivity for analysis of circulating tumour DNA European Journal of Cancer. 61: S4. DOI: 10.1016/S0959-8049(16)61008-0  0.01
2015 Plagnol V, Lawson A, Forshew T, Fahem A, Brenton J, Gale D, Rosenfeld N. Assessment of clinical applications of circulating tumor DNA using an enhanced TAm-Seq platform. Journal of Clinical Oncology. 33: e22057-e22057. DOI: 10.1200/Jco.2015.33.15_Suppl.E22057  0.01
2014 Tsui D, Wong A, Murtaza M, Forshew T, Soo R, Lim H, Goh B, Gale D, Chin T, Rosenfeld N. 58: Proffered Paper: Noninvasive monitoring of tumour mutations and dynamics in circulating DNA of non-small cell lung cancer patients treated with EGFR inhibitors European Journal of Cancer. 50: S14-S15. DOI: 10.1016/S0959-8049(14)50058-5  0.01
2014 Weaver JM, Ross-Innes C, Shannon NB, Lynch A, Forshew T, Barbera M, Ong CJ, Murtaza M, Lao-Sirieix P, Dunning MJ, Smith L, Smith M, Carvalho B, Underwood T, May A, ... ... Rosenfeld N, et al. 935 The Timing of Oncogenic Events in the Evolution of the Oesophageal Adenocarcinoma Genome and Implications for Clinical Diagnostics Gastroenterology. 146: S-161. DOI: 10.1016/S0016-5085(14)60576-X  0.01
2013 Voon PJ, Tsui DW, Rosenfeld N, Chin TM. EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib--Letter. Molecular Cancer Therapeutics. 12: 2614-5. PMID 23969006 DOI: 10.1158/1535-7163.MCT-13-0192  0.01
2013 Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N, Rozenfeld N, Harpaz N, Itzkowitz S, Harris CC, Rotter V, et al. Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell. 23: 634-46. PMID 23680148 DOI: 10.1016/J.Ccr.2013.03.022  0.01
2012 Dawson S, Tsui D, Murtaza M, Biggs H, Chin S, Gale D, Forshew T, Wallis M, Caldas C, Rosenfeld N. 876 Non-invasive Monitoring of Metastatic Breast Cancer by Circulating Tumour DNA – a Comparison With Circulating Tumour Cells European Journal of Cancer. 48: S211-S212. DOI: 10.1016/S0959-8049(12)71508-3  0.01
2012 Dawson S, Tsui D, Murtaza M, Biggs H, Chin S, Gale D, Forshew T, Wallis M, Rosenfeld N, Caldas C. Monitoring of Metastatic Breast Cancer Using Circulating Tumour DNA: A Comparison With Circulating Tumour Cells Annals of Oncology. 23: ix74. DOI: 10.1016/s0923-7534(20)32772-1  0.01
2009 Rosenwald S, Gibori H, Gilad S, Cohen L, Leizerman I, Barshack I, Nonaka D, Tobar A, Aharonov R, Rosenfeld N. Identification of tumor tissue origin by a microRNA-based molecular assay. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 11036. PMID 27964010 DOI: 10.1200/jco.2009.27.15_suppl.11036  0.01
2009 Lebanony D, Benjamin H, Gilad S, Ashkenazi K, Nonaka D, Feinmesser M, Rosenfeld N, Chajut A, Cohen D, Aharonov R. MicroRNA-based assay for differential diagnosis of squamous from non-squamous non-small cell lung carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 11069. PMID 27963144 DOI: 10.1200/jco.2009.27.15_suppl.11069  0.01
2008 Benjamin H, Lebanony D, Cohen L, Elyakim E, Rosenfeld N, Chajut A, Cohen D. Differential diagnosis of mesothelioma using a microRNA assay Journal of Clinical Oncology. 26: 22000-22000. DOI: 10.1200/JCO.2008.26.15_SUPPL.22000  0.01
2008 Nass D, Rosenwald S, Sitbon E, Lithwick G, Elyakim E, Cholakh H, Spector Y, Rosenfeld N, Aharonov R, Barshack I, Bentwich Z. MicroRNAs as specific biomarkers for distinguishing between primary and metastatic brain tumors Journal of Clinical Oncology. 26: 13002-13002. DOI: 10.1200/jco.2008.26.15_suppl.13002  0.01
2008 Rosenwald S, Meiri E, Gilad S, Ezagouri M, Spector Y, Ben Ari A, Levy A, Aharonov R, Rosenfeld N, Barshack I. MicroRNA signature identifies tissue origin of primary and metastatic tumors Journal of Clinical Oncology. 26: 11028-11028. DOI: 10.1200/jco.2008.26.15_suppl.11028  0.01
2008 Barshack I, Rosenwald S, Bronfeld M, Aviel-Ronen S, Meiri E, Zepeniuk M, Shabes N, Tabak S, Cohen D, Rosenfeld N. MicroRNA expression profile identifies origin of tumors in the liver Journal of Clinical Oncology. 26: 11026-11026. DOI: 10.1200/jco.2008.26.15_suppl.11026  0.01
Hide low-probability matches.